In AFib with diabetes, tirzepatide was linked to fewer strokes than other GLP-1 drugs
Among 14,118 matched pairs of adults with atrial fibrillation and type 2 diabetes, starting tirzepatide was linked to lower risks of stroke and death than starting another GLP-1 drug, with absolute differences…